| Document Date: 2014-03-31 07:24:11
Open Document File Size: 41,43 KBShare Result on Facebook
City South San Francisco / Rockville / / Company Development Chief Medical Officer Genentech Inc. / F. Hoffmann-La Roche Ltd / Genentech Inc. / / Country United States / Canada / / Event FDA Phase / / / IndustryTerm treatment of metastatic colorectal cancer / Healthcare professionals / / MedicalCondition metastatic non-squamous / non-small cell lung cancer / congestive heart failure / hypertension / headache / NSCLC / fatal / pulmonary hemorrhage / leukopenia / asthenia / abdominal pain / neutropenia / nausea / reversible posterior leukoencephalopathy syndrome / metastatic colorectal cancer / ileus / hemoptysis / nephrotic syndrome / intra-abdominal abscess / subarachnoid hemorrhage / syncope / pain / vomiting / fatigue / deep vein thrombosis / hemorrhagic stroke / serious intraocular inflammatory reactions / diarrhea / infection / constipation / intra-abdominal thrombosis / dehydration / / MedicalTreatment elective surgery / chemotherapy / / Organization FDA / Avastin administration / / Person Hal Barron / / / Position Vice President / / Product carboplatin / paclitaxel / AVASTIN / Intraocular Inflammatory Reactions After Intravitreal Injection / AVASTIN® (bevacizumab) / / ProvinceOrState Maryland / California / / Technology chemotherapy / / URL www.accessdata.fda.gov/scripts/medwatch / /
SocialTag |
1 DNA Way South San Francisco, CA[removed][removed]FAX: ([removed]December 19, 2008